1. Safety and Effectiveness of Bevacizumab-Containing Treatment for Non–Small-Cell Lung Cancer: Final Results of the ARIES Observational Cohort Study 
Thomas J. Lynch, MD, David R. Spigel, MD, Julie Brahmer, MD, Neal Fischbach, MD, Jennifer Garst, MD, Mohammad Jahanzeb, MD, Priya Kumar, MD, Regina M. Vidaver, MD, Antoinette J. Wozniak, MD, Susan Fish, MS, E. Dawn Flick, MPH, Larry Leon, PhD, Sebastien J. Hazard, MD, Michael P. Kosty, MD 
Journal of Thoracic Oncology 
Volume 9, Issue 9, Pages (September 2014)
DOI: /JTO
Copyright © 2014 International Association for the Study of Lung Cancer Terms and Conditions

2. FIGURE 1 Baseline chemotherapy use by period of study enrollment.
Journal of Thoracic Oncology 2014 9, DOI: ( /JTO )
Copyright © 2014 International Association for the Study of Lung Cancer Terms and Conditions

3. FIGURE 2
Kaplan-Meier curves of (A) progression-free survival and (B) overall survival in non–small-cell lung cancer patients in the ARIES (Avastin Regimens: Investigation of Effectiveness and Safety) trial.
Journal of Thoracic Oncology 2014 9, DOI: ( /JTO )
Copyright © 2014 International Association for the Study of Lung Cancer Terms and Conditions